Key Insights into the Typhoid Vi Polysaccharide Vaccine Market: Trends, Growth Rate, and Opportunities Through 2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTyphoid Vi Polysaccharide Vaccine Market?
The escalating occurrence of typhoid is projected to fuel the expansion of the typhoid VI polysaccharide vaccine market in the future. Typhoid, a potentially deadly infection, is brought on by the bacterium Salmonella typhi and primarily spreads via contaminated food or drink. The vaccine against typhoid Vi polysaccharide is utilized to protect children over the age of 2 and adults from typhoid fever induced by Salmonella enterica serovar Typhi, or S. Typhi. For example, in August 2024, the UK Health Security Agency, a government entity, published data indicating that laboratory-confirmed symptomatic cases of enteric fever in England, Wales and Northern Ireland saw an uptick from 2021 to 2022, with occurrences of S. Typhi increasing from 108 to 313, S. Paratyphi A from 31 to 135, and S. Paratyphi B from 13 to 18. As such, the growing prevalence of typhoid is spurring on the typhoid Vi polysaccharide vaccine market’s growth.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8313&type=smp
#What Long-Term Growth Rate is Expected for theTyphoid Vi Polysaccharide Vaccine Market Between 2025 and 2034?
In recent times, the market for typhoid vi polysaccharide vaccine has experienced swift expansion. From 2024 to 2025, there would be a significant increase in its value from $5.78 billion to $6.77 billion, showing a compound annual growth rate (CAGR) of 17.1%. The noteworthy growth during the historical period can be credited to factors such as the prevalence of the disease, international health campaigns, vaccination of travelers, governmental efforts towards immunisation, and the efficacy and safety of the vaccine.
In the forthcoming years, the market size of the typhoid vi polysaccharide vaccine is projected to experience swift expansion. By 2029, its valuation is set to reach $13.36 billion, with a compound annual growth rate (CAGR) of 18.5%. The projected growth during the prediction period is predominantly due to the enhancement of immunization initiatives, focus on global health policies, epidemiological surveillance, an increase in demand within travel medicine, and environmental and societal factors. The forecast period also signifies significant trends including investment in research and development, regulatory support, epidemiological research, and public health awareness.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8313
What Are the Current Market Growth and Trends in theTyphoid Vi Polysaccharide Vaccine Market That Industry Players Should Watch?
There is an increasing trend in the typhoid Vi polysaccharide vaccine market towards strategic collaborations. In order to secure their positioning within the sector, major firms are establishing partnerships with others. For instance, in July 2022, The International Vaccine Institute from South Korea, dedicated to fighting globally significant infectious diseases such as cholera, typhoid, shigella, and salmonella, formed a partnership with US-based biopharmaceutical corporation Moderna. This collaboration resulted in the creation of a cost-effective oral cholera vaccine and a new-generation typhoid conjugate vaccine, representing a world first.
What Are the Major Market Players Making an Impact on theTyphoid Vi Polysaccharide Vaccine Market Growth?
Major companies operating in the typhoid vi polysaccharide vaccine market are Sanofi S.A., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Emergent Biosolutions Inc., PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Bio-Med Pvt. Ltd., LG Chem, SK Chemicals Co. Ltd., Crucell Switzerland AG, Hualan Biological Engineering Inc., Indian Immunologicals Limited
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Typhoid Vi Polysaccharide Vaccine Market Driving Opportunities and Innovations?
The typhoid vi polysaccharide vaccine market covered in this report is segmented –
1) By Type: Child, Adult
2) By Route Of Administration: Oral, Parenteral
3) By Application: Government Institution, Private Sector, Other Applications
Subsegments:
1) By Child: Pediatric Formulations, Age-Specific Dosages
2) By Adult: Standard Adult Formulations, High-Risk Population Formulations
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8313&type=smpGlobal Typhoid Vi Polysaccharide Vaccine Market, Global Typhoid Vi Polysaccharide Vaccine Market Report, Global Typhoid Vi Polysaccharide Vaccine Market Trends, Global Typhoid Vi Polysaccharide Vaccine Market Size
Browse Through More Reports Similar to the Gobal Typhoid Vi Polysaccharide Vaccine Maret 2025, By The Business Research Company:
Pediatric Vaccine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
DTP Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
